Melanoma, Skin cancer
Results
Phase 2/3
This trial aimed to measure small amounts of melanoma cancer cells that may be in the bloodstream after surgery.
Depending on the results some people would go on to have treatment with a drug called nivolumab.
The trial was for people who had early stage melanoma. This is stage 2B or 2C melanoma.
Cancer Research UK supported this trial.
Recruitment start: 9 November 2021
Recruitment end: 30 January 2023
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Paul Lorigan
Cancer Research UK
The Christie NHS Foundation Trust
This is Cancer Research UK trial number CRUK/19/010.
Last reviewed: 21 March 2023
CRUK internal database number: 17882
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
